Feedback / Questions
RGB 03 (rituximab biosimilar) - Stada, Gedeon Richter
Stada: Capital Markets Day 2016
(Stada)
-
Oct 8, 2016 -
Anticipated launch in hematological malignancies and autoimmune disorders in 2019
Anticipated biosimilar launch
•
Biosimilar
https://www.stada.com/fileadmin/user_upload/A_stada.de/5_Investor_Relations.de/05_Finanzpublikationen/002_CMD/2016/STADA_Capital_Markets_Day_Slegers.pdf
Oct 8, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious